The BEXXAR (R) therapeutic regimen (Tositumomab and iodine I 131 tositumomab) can be safely administered to patients over the age of 70. Gregory, S. A., Zelenetz, A. D., Knox, S. J., Vase, J. M., Kaminski, M. S. AMER SOC HEMATOLOGY. 2003: 409A

View details for Web of Science ID 000186536701485